the invention relates to compounds acting as selective antagonists of transient receptor potential cation channel subfamily m member 8 , and having formula . said compounds are useful in the treatment of diseases associated with activity of trpm8 such as pain , inflammation , ischaemia , neurodegeneration , stroke , psychiatric disorders , itch , irritable bowel diseases , cold induced and / or exhacerbated respiratory disorders and urological disorders .